1747P - The need for a better discussion between doctors and patients with regards to fertility preservation and vaginal rehab after anti cervical cancer treatments

Background

Cervical cancer patients' age is relatively young (considering only 35-39 and not 60-64). At this young age, patients might consider birth planning and other sexual health considerations such as vaginal rehabilitation.

Methods

A call for answers to a survey was published and patients and verified survivors were invited to respond voluntarily and anonymously through a coded and encrypted web form.

Results

116 women responded to the survey (age 21-72, median=42, age range at diagnosis 18-65). 8% were diagnosed with CIN1-2, 43% with CIN3, 20% with stage 1, 7% with stage 2, 10% with stages 3-4, 12% did not know how to answer. Past treatments were recorded. 84% of those required to use a vaginal dilator did not do so (results were modified in accordance to guidelines). At childbearing age [67 women, ages 21-45, median=37; 55.22% CIN3, 19.4% stage 1, 5.97% stage 2, 5.97% stages 3-4, 13.43% did not know how to answer; 77.61% were sexually active with a single known partner], only 58.2% recall having a discussion with their physician regarding fertility preservation, before beginning treatments. 32.83% recall such a discussion afterwards. 11.94% give birth after illness or had a child thanks to a surrogate mother.

Conclusions

This study underscores the need for greater attention to patients’ sexual health and fertility aspects before and after completion of treatments. There is a need in coordinate patients' expectations regarding birth planning and in making the information regarding vaginal dilator accessible. Research involving a larger sample size may help to better support the information needs of survivors.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

HaBait Shel Bar – Israel’s Women’s Cancer Association (RA).

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.